Loading…
Based on limited metadata, Coral Pharmaceuticals LTD received an FDA Warning Letter on October 9, 2019, regarding drug products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in this metadata. Additional details about the company's manufacturing practices, compliance issues, or product-specific concerns would require review of the complete warning letter.